Retrospective Cohort Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Apr 14, 2016; 22(14): 3785-3792
Published online Apr 14, 2016. doi: 10.3748/wjg.v22.i14.3785
Table 1 Predisposition, injury and response according to the subtypes n (%)
Type A (n = 34)Type B (n = 53)Type C (n = 80)P value
Age (yr)c51.9 ± 10.354.0 ± 10.358.0 ± 11.10.010
Male20 (58.8)32 (60.4)59 (73.8)0.159
Predisposition
HBVc21 (61.8)19 (35.9)28 (35.0)0.020
Alcoholac4 (11.8)25 (47.2)33 (41.3)0.001
HCV0 (0.0)0 (0.0)6 (7.5)0.051
Autoimmunec6 (17.7)2 (3.8)2 (2.5)0.008
Others3 (8.8)7 (13.2)11 (13.8)0.827
Injury
Hepaticace30 (88.2)31 (58.5)9 (11.3)< 0.001
Extrahepaticace0 (0.0)13 (24.5)44 (55.0)< 0.001
Unknowne4 (11.8)4 (7.6)23 (28.8)0.005
Both (hepatic + extrahepatic)0 (0.0)5 (9.4)4 (5.0)0.165
Response
MELD score29 ± 8.327 ± 5.726 ± 6.30.137
SIRS9 (26.5)19 (35.9)30 (37.5)0.516
Organ failures by CLIF-SOFA
Type of organ failure
Nonee8 (23.5)8 (15.1)28 (35.0)0.035
Hepatic/coagulationce19 (55.9)34 (64.2)21 (26.3)0.000
Extrahepaticc7 (20.6)11 (20.8)31 (38.8)0.038
Specific organ type
Hepaticce26 (76.5)42 (79.3)28 (35.0)< 0.001
Coagulation10 (29.4)11 (20.8)21 (26.3)0.630
Renal7 (20.6)5 (9.4)17 (21.3)0.182
Cerebral2 (5.9)4 (7.6)11 (13.8)0.418
Circulatoryce1 (2.9)4 (7.6)16 (20.0)0.021
Respiratory2 (5.9)1 (1.9)4 (5.0)0.679
Number of organ failure
Nonee8 (23.5)8 (15.1)28 (35.0)0.035
Onee13 (38.2)29 (54.7)26 (32.5)0.036
≥ 213 (38.2)16 (30.2)26 (32.5)0.733
Table 2 Specific injury according to the acute on chronic liver failure type n (%)
Type AType BType CP value
HBV flareace17 (50.0)11 (20.8)4 (5.0)< 0.001
Alcoholae3 (8.8)19 (35.9)6 (7.5)< 0.001
HAV3 (8.8)1 (1.9)1 (1.3)0.130
Toxine5 (14.7)9 (17.0)3 (3.8)0.021
AIH flarec7 (20.6)2 (3.8)0 (0.0)< 0.001
Infectionac0 (0.0)13 (24.5)32 (40.0)< 0.001
Varix bleeding0 (0.0)3 (5.7)11 (13.8)0.035
Other bleeding0 (0.0)2 (3.8)6 (7.5)0.215
Unknowne4 (11.8)4 (7.6)23 (28.8)0.005